Clearline Capital LP Makes New Investment in Henry Schein, Inc. $HSIC

Key Points

• Clearline Capital LP acquired a new position in Henry Schein, Inc., purchasing 234,998 shares valued at approximately $16.1 million, constituting 1.0% of its investment portfolio.
• Henry Schein's stock price recently opened at $69.43, showing a market capitalization of $8.42 billion and a P/E ratio of 22.40.
• Although Henry Schein reported quarterly earnings that missed analysts' estimates, the company experienced a revenue increase of 3.3% compared to the previous year.

Clearline Capital LP purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 234,998 shares of the company's stock, valued at approximately $16,095,000. Henry Schein accounts for approximately 1.0% of Clearline Capital LP's investment portfolio, making the stock its 22nd largest position. Clearline Capital LP owned 0.19% of Henry Schein as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Investment Management Corp VA ADV purchased a new stake in Henry Schein during the 4th quarter worth $32,000. Rakuten Securities Inc. purchased a new position in Henry Schein in the 1st quarter valued at about $34,000. Whittier Trust Co. boosted its position in Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after buying an additional 700 shares during the last quarter. Quarry LP purchased a new position in Henry Schein in the 1st quarter valued at about $71,000. Finally, UMB Bank n.a. boosted its position in Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Down 0.8%

Shares of HSIC stock traded down $0.54 during trading hours on Friday, hitting $69.01. 1,115,039 shares of the company were exchanged, compared to its average volume of 1,429,852. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The business's 50-day simple moving average is $69.32 and its two-hundred day simple moving average is $69.48. The stock has a market capitalization of $8.37 billion, a price-to-earnings ratio of 22.26, a P/E/G ratio of 2.29 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the previous year, the business posted $1.23 EPS. The business's revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of analyst reports. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective for the company in a research report on Tuesday, August 26th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Sunday, September 7th. Robert W. Baird reissued a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th. Finally, Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.